[Form 4] Lumentum Holdings Inc. Insider Trading Activity
Rhea-AI Filing Summary
Matthew Joseph Sepe, Chief Accounting Officer of Lumentum Holdings Inc. (LITE), reported a tax-withholding disposition related to vested restricted stock units. On 08/15/2025, 837 shares of common stock were disposed (Transaction Code F(1)) at an indicated price of $115.86 per share to satisfy income tax withholding and remittance obligations tied to RSU vesting. After the withholding, Sepe beneficially owned 37,591 shares, held directly. The Form 4 was executed by an attorney-in-fact, Jae Kim, on 08/19/2025. The filing identifies Sepe as an officer of the issuer.
Positive
- Transparency: The filing clearly discloses the withholding transaction and provides an explanation linking it to RSU vesting.
- Continued insider ownership: The reporting person retains 37,591 shares after the withholding, maintaining alignment with shareholders.
Negative
- Disposition recorded: 837 shares were disposed of (withheld) on 08/15/2025, reducing direct shareholdings.
- No market context provided: The Form 4 does not state whether any additional planned sales or compensation events exist.
Insights
TL;DR: Routine insider tax-withholding sale of RSUs; ownership remains material but this is not an open-market sell.
The Form 4 documents a withholding disposition of 837 shares at $115.86 to satisfy tax obligations from RSU vesting. Such transactions are common compensation-related transfers and do not indicate a voluntary market sale by the officer. Remaining direct beneficial ownership of 37,591 shares preserves alignment with shareholders. No additional sales, derivative transactions, or changes in control are disclosed.
TL;DR: Governance routine: officer RSU withholding reported correctly, executed via attorney-in-fact.
The filing correctly uses Transaction Code F(1) with an explicit explanatory note that shares were withheld to satisfy income tax withholding on vested RSUs. The report names the reporting person as Chief Accounting Officer and shows the Form 4 was signed by an attorney-in-fact, which is a standard administrative practice. No indications of extraordinary compensation events or governance concerns are present in the disclosed text.